Liposome drug form with light-converting nanoparticles, a method of its preparation and use

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F67985823%3A_____%2F21%3A00551057" target="_blank" >RIV/67985823:_____/21:00551057 - isvavai.cz</a>
Result on the web
<a href="https://worldwide.espacenet.com/publicationDetails/originalDocument?FT=D&date=20211110&DB=&locale=en_EP&CC=EP&NR=3697385B1&KC=B1&ND=4" target="_blank" >https://worldwide.espacenet.com/publicationDetails/originalDocument?FT=D&date=20211110&DB=&locale=en_EP&CC=EP&NR=3697385B1&KC=B1&ND=4</a>
DOI - Digital Object Identifier
—

Result language
angličtina
Original language name
Liposome drug form with light-converting nanoparticles, a method of its preparation and use
Original language description
A liposome drug form is applied intravenously and subsequently irradiated with laser at wavelength in the infrared spectrum which passes deep into tissue. Nanoparticles convert the infrared radiation to wavelength of 670nm which activates phtalocyanines and subsequently disintegration of the tumor tissue.
Czech name
—
Czech description
—

Project
<a href="/en/project/GA19-00676S" target="_blank" >GA19-00676S: Biocompatible surface-engineered upconversion nanoparticles for cancer therapy</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Publication year
2021
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Patent/design ID
EP3697385
Publisher
EPO_1 -
Publisher name
European Patent Office
Place of publication
Munich, The Hague, Berlin, Vienna, Brussels
Publication country
—
Date of acceptance
Nov 10, 2021
Owner name
Fyziologický ústav AV ČR, v. v. i.
Method of use
A - Výsledek využívá pouze poskytovatel
Usage type
P - Využití výsledku jiným subjektem je v některých případech možné bez nabytí licence

Similar results(10)